Literature DB >> 18665776

Animal models in influenza vaccine testing.

Jan Willem van der Laan1, Carla Herberts, Robert Lambkin-Williams, Alison Boyers, Alexander J Mann, John Oxford.   

Abstract

The threat of a pandemic outbreak of influenza A H5N1 and H2N2 has brought attention to the development of new vaccines. Regulatory authorities require companies to provide data proving the effectiveness of vaccines, which cannot, however, be based on real efficacy data in humans. A weight-of-evidence approach may be used, based on evidence of protection in an appropriate animal model and the satisfaction of the surrogate end points in the clinical situation. In this review, we will discuss various animal species that can be infected with influenza. The main animals used for testing vaccines destined for human use are laboratory mice and ferrets and, to a lesser extent, macaques. We will focus particularly on these species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18665776     DOI: 10.1586/14760584.7.6.783

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN: 1476-0584            Impact factor:   5.217


  48 in total

1.  Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein.

Authors:  Ruth V Bushnell; John K Tobin; Jinxue Long; Stacey Schultz-Cherry; A Ray Chaudhuri; Peter L Nara; Gregory J Tobin
Journal:  Virol J       Date:  2010-08-24       Impact factor: 4.099

2.  Mouse STAT2 restricts early dengue virus replication.

Authors:  Joseph Ashour; Juliet Morrison; Maudry Laurent-Rolle; Alan Belicha-Villanueva; Courtney Ray Plumlee; Dabeiba Bernal-Rubio; Katherine L Williams; Eva Harris; Ana Fernandez-Sesma; Christian Schindler; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

Review 3.  Fast vaccine design and development based on correlates of protection (COPs).

Authors:  Cécile van Els; Siri Mjaaland; Lisbeth Næss; Julia Sarkadi; Eva Gonczol; Karen Smith Korsholm; Jon Hansen; Jørgen de Jonge; Gideon Kersten; Jennifer Warner; Amanda Semper; Corine Kruiswijk; Fredrik Oftung
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

4.  Evaluation of multivalent H2 influenza pandemic vaccines in mice.

Authors:  Brian J Lenny; Stephanie Sonnberg; Angela F Danner; Kimberly Friedman; Richard J Webby; Robert G Webster; Jeremy C Jones
Journal:  Vaccine       Date:  2017-02-08       Impact factor: 3.641

5.  Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB/c, C57BL/2, Swiss-Webster, and DBA.2 mice.

Authors:  Almut H Vollmer; Makda S Gebre; Dale L Barnard
Journal:  Antiviral Res       Date:  2016-08-11       Impact factor: 5.970

6.  Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous alpha interferon to reduce virus shedding.

Authors:  Neal Van Hoeven; Jessica A Belser; Kristy J Szretter; Hui Zeng; Peter Staeheli; David E Swayne; Jacqueline M Katz; Terrence M Tumpey
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

7.  Transcriptome sequencing and development of an expression microarray platform for the domestic ferret.

Authors:  Carl E Bruder; Suxia Yao; Francis Larson; Jeremy V Camp; Ronald Tapp; Alexis McBrayer; Nicholas Powers; Willy Valdivia Granda; Colleen B Jonsson
Journal:  BMC Genomics       Date:  2010-04-19       Impact factor: 3.969

8.  The mouse model is suitable for the study of viral factors governing transmission and pathogenesis of highly pathogenic avian influenza (HPAI) viruses in mammals.

Authors:  Michela Rigoni; Anna Toffan; Elisabetta Viale; Marzia Mancin; Filippo Cilloni; Elena Bertoli; Angela Salomoni; Sabrina Marciano; Adelaide Milani; Bianca Zecchin; Ilaria Capua; Giovanni Cattoli
Journal:  Vet Res       Date:  2010-06-15       Impact factor: 3.683

Review 9.  Animal models for the study of influenza pathogenesis and therapy.

Authors:  Dale L Barnard
Journal:  Antiviral Res       Date:  2009-01-25       Impact factor: 5.970

10.  New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets.

Authors:  Robert H E Friesen; Wouter Koudstaal; Martin H Koldijk; Gerrit Jan Weverling; Just P J Brakenhoff; Peter J Lenting; Koert J Stittelaar; Albert D M E Osterhaus; Ronald Kompier; Jaap Goudsmit
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.